3651 results for «217»
3651 results
Transcatheter solutions in young and congenital heart disease patients
17 Nov 2025 – From PCR London Valves 2025
This session focuses on transcatheter solutions tailored for young and congenital heart disease patients, featuring challenging edge-to-edge repair in extracardiac Fontan physiology, systemic AV valve TEER in congenital anomalies, multidisciplinary management of repaired tetralogy of Fallot with tricuspid regurgitation, innovative TAVI in young congenital patients, and...
Pills and pumps: targeting heart failure before and after surgical and transcatheter valve interventions
18 Nov 2025 – From PCR London Valves 2025
This session examines the integrated role of heart failure therapies in the peri- and post-procedural management of patients undergoing surgical and transcatheter valve interventions. It reviews current and emerging clinical trial data, discusses identifying high-risk patients, and explores advanced modalities such as cardiac resynchronization and circulatory...
Getting to the heart of access: mastering femoral puncture and vascular closure
18 Nov 2025 – From PCR London Valves 2025
This session provides an in-depth understanding of femoral anatomy and the critical role of imaging in ensuring safe vascular access via femoral puncture. It covers the latest equipment used for vascular access and closure, highlighting haemostasis techniques and closure devices. Interactive case scenarios offer practical insights...
Featured research - Mitral valve interventions - Part 4
18 Nov 2025 – From PCR London Valves 2025
This research-focused session presents contemporary evidence and clinical outcomes related to mitral valve interventions. It includes data on transapical mitral valve-in-ring implantation from the European Tendyne registry, prognostic utility of CT-derived fatty muscle fraction in mitral TEER, and comparative outcomes between transapical TMVR and mitral TEER....
Paravalvular leak closure - Part 3
18 Nov 2025 – From PCR London Valves 2025
This session addresses the complexities of paravalvular leak closure, emphasizing resilience in procedural approaches. It covers sizing balloon techniques that enhance treatment efficacy in aortic paravalvular leaks and explores closure strategies following Ozaki procedures. Management of mitral paravalvular leaks in high-risk patients and innovative solutions for...
TAVI complications - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session explores complex and uncommon complications associated with TAVI procedures, highlighting challenging clinical scenarios such as neurological complications in bicuspid valves, management of critically unstable left ventricles, and outcomes in complex valve interventions. Each topic offers valuable lessons for improving procedural safety and patient outcomes...
Featured research - TAVI - Part 14
18 Nov 2025 – From PCR London Valves 2025
This featured research session presents pivotal findings on transcatheter aortic valve implantation (TAVI), including 30-day and one-year outcomes from the VANTAGE trial, novel concepts for assessing aortic stenosis severity, and the influence of mitral annular calcification on conduction disturbances. Additional topics cover the role of clinical...
TAVI in challenging anatomies
18 Nov 2025 – From PCR London Valves 2025
This session focuses on the challenges of performing TAVI in complex anatomical settings. It covers issues such as valve compression, hypertrophic cardiomyopathy-related left ventricular responses, alternative management strategies during crises, and handling anatomical complexities like membranous septal aneurysm at the annulus and sinus of Valsalva in...
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease
30 Aug 2022
Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona
Author
TRIGISTRY: Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE
31 Aug 2024
Alex Sticchi provides his take on the TRIGISTRY study presented by Julien Dreyfus at the ESC Congress 2024 in London.
Simultaneous publication in European Heart Journal, ehae578
Author
EuroPCR 2024: Elixir Medical’s late-breaking 12-month data demonstrate significant improvement in safety and effectiveness of world’s first site-specific antithrombotic therapeutic compared to DES
14 May 2024